These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 10160261)
1. 'Clandestine' prostate cancer haunts. Chapman B CAP Today; 1996 Feb; 10(2):1, 34-6, 38 passim. PubMed ID: 10160261 [No Abstract] [Full Text] [Related]
2. Hormone ablation therapy: lightening the load for today's prostate cancer patient. Matthews PA Urol Nurs; 2007 Feb; 27 Suppl():3-11. PubMed ID: 17474637 [TBL] [Abstract][Full Text] [Related]
3. [New development of endocrine therapy in prostate cancer]. Naito S Gan To Kagaku Ryoho; 1996 May; 23(6):684-8. PubMed ID: 8645018 [TBL] [Abstract][Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer. Smith MR; Zietman AL; Finkelstein JS; Wu CL N Engl J Med; 2011 May; 364(21):2044-51. PubMed ID: 21612474 [No Abstract] [Full Text] [Related]
8. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate]. Boccon-Gibod L Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748 [No Abstract] [Full Text] [Related]
18. Luteinizing hormone-releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant. Marks LS Urology; 2003 Dec; 62(6 Suppl 1):36-42. PubMed ID: 14706507 [TBL] [Abstract][Full Text] [Related]
19. [What is safe in the therapy of advanced prostatic cancer?]. Gropp C; Burk K Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819 [No Abstract] [Full Text] [Related]
20. Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma. Ogan K; Berger M; Ball R J Urol; 1998 Aug; 160(2):497-8. PubMed ID: 9679910 [No Abstract] [Full Text] [Related] [Next] [New Search]